$RNXT is addressing the under-served area of oncology today such as bile duct cancer. Their collaboration with The University of Oklahoma should be of high value in making progress in this key medical industry niche that can help where it is really needed.

RenovoRx Engaged Oklahoma University (OU) Health as First Clinical Site in Preparation for the Pivotal Phase III CouGar Clinical Trial in Bile Duct Cancer
Click here:
https://www.businesswire.com/news/home/202312...ialnetwork